These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33046728)

  • 1. Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice.
    El Bissati K; Zhou Y; Paulillo SM; Raman SK; Karch CP; Reed S; Estes A; Estes A; Lykins J; Burkhard P; McLeod R
    Sci Rep; 2020 Oct; 10(1):16984. PubMed ID: 33046728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 mice.
    Cong H; Mui EJ; Witola WH; Sidney J; Alexander J; Sette A; Maewal A; El Bissati K; Zhou Y; Suzuki Y; Lee D; Woods S; Sommerville C; Henriquez FL; Roberts CW; McLeod R
    Hum Immunol; 2012 Jan; 73(1):1-10. PubMed ID: 22027386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice.
    El Bissati K; Zhou Y; Dasgupta D; Cobb D; Dubey JP; Burkhard P; Lanar DE; McLeod R
    Vaccine; 2014 May; 32(26):3243-8. PubMed ID: 24736000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201.
    Cong H; Mui EJ; Witola WH; Sidney J; Alexander J; Sette A; Maewal A; McLeod R
    Vaccine; 2011 Jan; 29(4):754-62. PubMed ID: 21095258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.
    Cao A; Liu Y; Wang J; Li X; Wang S; Zhao Q; Cong H; He S; Zhou H
    Vaccine; 2015 Nov; 33(48):6757-62. PubMed ID: 26518401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against
    El Bissati K; Chentoufi AA; Krishack PA; Zhou Y; Woods S; Dubey JP; Vang L; Lykins J; Broderick KE; Mui E; Suzuki Y; Sa Q; Bi S; Cardona N; Verma SK; Fraczek L; Reardon CA; Sidney J; Alexander J; Sette A; Vedvick T; Fox C; Guderian JA; Reed S; Roberts CW; McLeod R
    JCI Insight; 2016 Sep; 1(15):e85955. PubMed ID: 27699241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of human MHC-I HPV18 E6/E7-specific CD8 + T cell epitopes and generation of an HPV18 E6/E7-expressing adenosquamous carcinoma in HLA-A2 transgenic mice.
    Peng S; Xing D; Ferrall L; Tsai YC; Hung CF; Wu TC
    J Biomed Sci; 2022 Oct; 29(1):80. PubMed ID: 36224625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans.
    Tan TG; Mui E; Cong H; Witola WH; Montpetit A; Muench SP; Sidney J; Alexander J; Sette A; Grigg ME; Maewal A; McLeod R
    Vaccine; 2010 May; 28(23):3977-89. PubMed ID: 20347630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8
    Xiang SD; Wilson KL; Goubier A; Heyerick A; Plebanski M
    Front Immunol; 2018; 9():2968. PubMed ID: 30631324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
    Sánchez-López EF; Corigliano MG; Albarracín RM; Sander VA; Legarralde A; Bengoa-Luoni SA; Clemente M
    Parasit Vectors; 2019 Mar; 12(1):140. PubMed ID: 30909938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection.
    Yin H; Zhao L; Wang T; Zhou H; He S; Cong H
    Parasit Vectors; 2015 Sep; 8():498. PubMed ID: 26420606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein nanovaccine confers robust immunity against
    El Bissati K; Zhou Y; Paulillo SM; Raman SK; Karch CP; Roberts CW; Lanar DE; Reed S; Fox C; Carter D; Alexander J; Sette A; Sidney J; Lorenzi H; Begeman IJ; Burkhard P; McLeod R
    NPJ Vaccines; 2017; 2():24. PubMed ID: 29263879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis.
    Chen J; Zhou DH; Li ZY; Petersen E; Huang SY; Song HQ; Zhu XQ
    Exp Parasitol; 2014 Apr; 139():42-8. PubMed ID: 24602875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8+T cell epitope based, adjuvanted vaccine protective against Toxoplasma gondii.
    Cong H; Mui EJ; Witola WH; Sidney J; Alexander J; Sette A; Maewal A; McLeod R
    Immunome Res; 2010 Dec; 6():12. PubMed ID: 21129215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection.
    Kim S; Li L; McMurtrey CP; Hildebrand WH; Weidanz JA; Gillanders WE; Diamond MS; Hansen TH
    J Immunol; 2010 Apr; 184(8):4423-30. PubMed ID: 20212098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxoplasma gondii-Derived Synthetic Peptides Containing B- and T-Cell Epitopes from GRA2 Protein Are Able to Enhance Mice Survival in a Model of Experimental Toxoplasmosis.
    Bastos LM; Macêdo AG; Silva MV; Santiago FM; Ramos EL; Santos FA; Pirovani CP; Goulart LR; Mineo TW; Mineo JR
    Front Cell Infect Microbiol; 2016; 6():59. PubMed ID: 27313992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Unusual MHC Molecule Generates Protective CD8+ T Cell Responses to Chronic Infection.
    Tsitsiklis A; Bangs DJ; Lutes LK; Chan SW; Geiger KM; Modzelewski AJ; Labarta-Bajo L; Wang Y; Zuniga EI; Dai S; Robey EA
    Front Immunol; 2020; 11():1464. PubMed ID: 32733483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
    Aparicio B; Casares N; Egea J; Ruiz M; Llopiz D; Maestro S; Olagüe C; González-Aseguinolaza G; Smerdou C; López-Díaz de Cerio A; Inogés S; Prósper F; Yuste JR; Carmona-Torre F; Reina G; Lasarte JJ; Sarobe P
    Emerg Microbes Infect; 2021 Dec; 10(1):1931-1946. PubMed ID: 34538222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
    Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.